Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women
- 1 January 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Menopause
- Vol. 16 (1), 77-83
- https://doi.org/10.1097/gme.0b013e31817b816e
Abstract
To determine the trend in incidence of fractures among perimenopausal and postmenopausal women during the periods immediately before and after publication of the Women's Health Initiative and Heart and Estrogen/Progestin Replacement Study (HERS) II data.This was an ecological study using a claims database for multiple healthcare plans. The cohort of women aged 40 to 69 years was included. Diagnostic codes for fractures likely to be osteoporosis related and prescriptions for hormone therapy and other bone-modifying medications were identified. Annual incidence rates and trends in incidence over time for fractures and prescriptions were determined for the period 2000 through 2005.Enrollment among women aged 40 to 69 years increased from 919,389 in 2000 to 2,872,372 in 2005. A total of 43,017 new fractures were identified. There was a significant increasing trend in age-adjusted rates of radius and ulna, vertebra, ribs, hip, pelvis, multiple, and pathologic fractures during the period from 2003 through 2005 (P < 0.03). The incidence of each fracture type was significantly greater during 2004 to 2005 than 2000 to 2001 (P < 0.04). The use of estrogen, estrogen plus progestin, and other hormones declined over the period from 2000 to 2003, whereas the use of other bone-modifying drugs increased from 2003 through 2005.The incidence of fractures among perimenopausal and postmenopausal women increased significantly in the 3 years after publication of Women's Health Initiative and Heart and Estrogen/Progestin Replacement Study II results. This trend followed a decline in the use of hormone therapy, concurrent with an increase in the use of other bone-modifying agents.Keywords
This publication has 43 references indexed in Scilit:
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized TrialJournal of Bone and Mineral Research, 2006
- The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors studyOsteoporosis International, 2005
- Fracture Incidence in Relation to the Pattern of Use of Hormone Therapy in Postmenopausal WomenPublished by American Medical Association (AMA) ,2004
- BMD at Multiple Sites and Risk of Fracture of Multiple Types: Long-Term Results From the Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2003
- Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral DensityThe Women's Health Initiative Randomized TrialJAMA, 2003
- Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fracturesOsteoporosis International, 2003
- Sex Steroids and the Construction and Conservation of the Adult SkeletonEndocrine Reviews, 2002
- Increased bone turnover in late postmenopausal women is a major determinant of osteoporosisJournal of Bone and Mineral Research, 1996